TRANSDERM SCOP Trademark

Trademark Overview

On Wednesday, January 26, 2011, a trademark application was filed for TRANSDERM SCOP with the United States Patent and Trademark Office. The USPTO has given the TRANSDERM SCOP trademark a serial number of 85226547. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, April 2, 2021. This trademark is owned by Novartis AG. The TRANSDERM SCOP trademark is filed in the Pharmaceutical Products category with the following description:

Scopolamine administered via transdermal infusion patches
transderm scop

General Information

Serial Number85226547
Word MarkTRANSDERM SCOP
Filing DateWednesday, January 26, 2011
Status800 - REGISTERED AND RENEWED
Status DateFriday, April 2, 2021
Registration Number4015693
Registration DateTuesday, August 23, 2011
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2011

Trademark Statements

Goods and ServicesScopolamine administered via transdermal infusion patches
NOT AVAILABLE"SCOP"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2011
Primary Code005
First Use Anywhere DateFriday, April 30, 1982
First Use In Commerce DateFriday, April 30, 1982

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDeerfield, IL 60015
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel
CH

Trademark Events

Event DateEvent Description
Saturday, January 29, 2011NEW APPLICATION ENTERED
Tuesday, June 7, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 31, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 16, 2011TEAS REQUEST TO MAKE SPECIAL RECEIVED
Thursday, February 17, 2011ASSIGNED TO PETITION STAFF
Friday, February 18, 2011REQUEST FOR SPECIAL HANDLING - GRANTED
Saturday, April 23, 2011ASSIGNED TO EXAMINER
Monday, April 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 27, 2011ASSIGNED TO LIE
Friday, April 29, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 7, 2011PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, August 23, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 10, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 23, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 16, 2017TEAS SECTION 8 & 15 RECEIVED
Thursday, May 4, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 10, 2017POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Saturday, May 20, 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, June 13, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 2, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, August 23, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 18, 2020TEAS SECTION 8 & 9 RECEIVED
Friday, April 2, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 2, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, April 2, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, April 16, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 16, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 16, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 16, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 16, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 16, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

scop transderm patches infusion transdermal administered scopolamine